跳至主要内容
临床试验/CTRI/2022/09/045180
CTRI/2022/09/045180招募中3 期

Efficacy of Epinephrine versus Nor-epinephrine as the initial vasoactive agent in Paediatric hematoncology patients with shock- A Feasibility Pilot study - NEO study

Apollo Hospitals0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Hematoncology patients aged 1 month to 17 years with early shock, defined as children with unresolved shock/hypoperfusion after the initial 10- 20ml/kg fluid bolus.

排除标准

  • 1.Children with fulminant myocarditis
  • 2.Children with established, untreated heart disease
  • 3.Parents not willing to participate in the study
  • 4.Caregiver/Physician unwilling for patient to be enrolled
  • 5.Post-arrest shock
  • 6.Moribund patients in whom anticipated survival < 24 hrs (since many are in recalcitrant downward spiral of overall condition where the impact of one or other vasoactive may be difficult to assess).

研究者

相似试验